Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Spero Therapeutics, Inc. | Chief Operating Officer | Common Stock | 63.6K | $80.7K | $1.27 | Feb 1, 2022 | Direct |
Spero Therapeutics, Inc. | Chief Operating Officer | Stock Option (Right to Buy) | 53.2K | $59.6K | $1.12 | Feb 1, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SPRO | Spero Therapeutics, Inc. | Feb 1, 2022 | 2 | $0 | 4 | Feb 3, 2022 | Chief Operating Officer |
SPRO | Spero Therapeutics, Inc. | Aug 26, 2021 | 1 | $0 | 4 | Aug 30, 2021 | Chief Operating Officer |